title: [Clinical evaluation of the hypotensive effectiveness of Betoptic preparation].
abstract: Clinical trials of the hypotensive effect of 0.5% betoptic, an antiglaucoma drug manufactured by Alcon (USA), were carried out at three ophthalmologic hospitals. Similar results obtained in all the trials permit a conclusion on a high hypotensive efficacy of this drug in patients with primary open-angle glaucoma. The drug was well tolerated by the patients.
authors.forename: V P
authors.initials: VP
authors.lastname: Erichev
authors.forename: M D
authors.initials: MD
authors.lastname: Abdulkadyrova
authors.forename: O M
authors.initials: OM
authors.lastname: Kalinina
authors.forename: V F
authors.initials: VF
authors.lastname: Shmyreva
authors.forename: A L
authors.initials: AL
authors.lastname: Polutornov
authors.forename: E A
authors.initials: EA
authors.lastname: Egorov
authors.forename: I A
authors.initials: IA
authors.lastname: Shmeleva
mesh_terms: D000368:Aged; D015784:Betaxolol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004361:Drug Tolerance; D005901:Glaucoma / Q000188:drug therapy*; D015812:Glaucoma, Angle-Closure / Q000188:drug therapy; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008875:Middle Aged; D013997:Time Factors
chemical_list: D015784:Betaxolol
vernacular_title: Klinicheskaia otsenka gipotenzivnoĭ éffektivnosti preparata "Betoptik".